Solanezumab for the treatment of mild-to-moderate Alzheimer’s disease
Year: 2012
Type: review
DOI: 10.1586/eci.11.93
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2142922534
